BibTex format
@article{Simpson-Yap:2021:10.1212/WNL.0000000000012753,
author = {Simpson-Yap, S and De, Brouwer E and Kalincik, T and Rijke, N and Hillert, JA and Walton, C and Edan, G and Moreau, Y and Spelman, T and Geys, L and Parciak, T and Gautrais, C and Lazovski, N and Pirmani, A and Ardeshirdavanai, A and Forsberg, L and Glaser, A and McBurney, R and Schmidt, H and Bergmann, AB and Braune, S and Stahmann, A and Middleton, R and Salter, A and Fox, RJ and van, der Walt A and Butzkueven, H and Alroughani, R and Ozakbas, S and Rojas, J and van, der Mei I and Nag, N and Ivanov, R and do, Olival GS and Dias, AE and Magyari, M and Brum, D and Mendes, MF and Alonso, RN and Nicholas, RS and Bauer, J and Chertcoff, AS and Zabalza, A and Arrambide, G and Fidao, A and Comi, G and Peeters, L},
doi = {10.1212/WNL.0000000000012753},
journal = {NEUROLOGY},
pages = {E1870--E1885},
title = {Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis},
url = {http://dx.doi.org/10.1212/WNL.0000000000012753},
volume = {97},
year = {2021}
}